Journal article · 2026 · Open access
PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES
Genetics and Molecular Research · Published 5 October 2026 · DOI 10.4238/6p76cf81
In brief
“PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES” is a 2026 journal article by Swathi Ratnam Regidi and 5 co-authors, published in Genetics and Molecular Research. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-SA licence: the full text is free to read at Genetics and Molecular Research.
- Citations
- 0
- References
- 48
- Authors
- 6
Abstract
Through an understanding of the role of inherited and acquired genetic variation in differences in drug metabolism, efficacy and toxicity, pharmacogenomics is changing the landscape of personalized drug therapy. In this review, the molecular and genetic basis of pharmacogenomic variability, clinically relevant biomarkers, enabling technologies, therapeutic applications, implementation pathways, and implications for clinical outcomes will be explored. Collectively, common variants, rare variants, copy-number variants, drug-target variation, and gene environment interactions contribute to pharmacokinetic (PK) and pharmacodynamic (PD) variability. Advances in targeted genotyping, next-generation and long-read sequencing, multi-omics, pharmacomicrobiomics, and artificial intelligence are expanding the ability to identify actionable biomarkers and predict individualized drug responses. The clinical use of genotype-based approaches is becoming increasingly apparent in cardiovascular medicine, oncology, psychiatry, HIV treatment, and transplantation, where genotype-based approaches can assist in drug selection, dose optimization, reduction of drug toxicity, and optimizing treatment response. Factors that continue to limit the translation to routine care include the availability of variable-strength evidence, cost of implementation, clinician preparedness, electronic health record integration, and population diversity. Further advances will require robust multi-gene models that have been validated, clinical decision support systems that can be interoperable across institutions, a more diverse population and the incorporation of genomic data with multi-omics and clinical data. Pharmacogenomics is thus an important avenue for improved precision prescribing, which is safer, more effective and more personalized.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Regidi, S. R., Johari, S., Singh, S., Kaur, N., Ahmad, F., & Chand, A. P. (2026). PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES. Genetics and Molecular Research. https://doi.org/10.4238/6p76cf81
MLA 9
Regidi, Swathi Ratnam, et al. “PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES.” Genetics and Molecular Research, 2026. https://doi.org/10.4238/6p76cf81.
Chicago
Regidi, Swathi Ratnam, Surabhi Johari, Sanskar Singh, Navjot Kaur, Fazil Ahmad, and Akkiraju Pavan Chand. 2026. “PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES.” Genetics and Molecular Research. https://doi.org/10.4238/6p76cf81.
Harvard
Regidi, S. R. et al. (2026) ‘PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES’, Genetics and Molecular Research. doi:10.4238/6p76cf81.
IEEE
S. R. Regidi, S. Johari, S. Singh, N. Kaur, F. Ahmad, and A. P. Chand, “PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES,” Genetics and Molecular Research, 2026, doi: 10.4238/6p76cf81.
BibTeX
@article{regidi2026pharmacogenomic,
title = {{PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES}},
author = {Regidi, Swathi Ratnam and Johari, Surabhi and Singh, Sanskar and Kaur, Navjot and Ahmad, Fazil and Chand, Akkiraju Pavan},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/6p76cf81},
url = {https://doi.org/10.4238/6p76cf81}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- individualized drug therapy
- precision medicine
- pharmacokinetic variability
- pharmacodynamic variability
- genetic variants
- copy number variation
- gene-environment interaction
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Regidi, S. R., Johari, S., Singh, S., Kaur, N., Ahmad, F., & Chand, A. P. (2026). PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES. Genetics and Molecular Research. https://doi.org/10.4238/6p76cf81
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Genetics and Molecular Research: sign in and open the PDF from this page.
Who wrote this paper?
Swathi Ratnam Regidi, Surabhi Johari, Sanskar Singh, Navjot Kaur, Fazil Ahmad, Akkiraju Pavan Chand.
What is the DOI of this paper?
10.4238/6p76cf81, permanently at https://doi.org/10.4238/6p76cf81. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.